Lanean...

Therapeutic Sequencing in Metastatic Renal Cell Carcinoma

The influx of multiple novel therapeutic options in the mRCC field has brought a challenge for treatment sequencing in this disease. In the past few years, cabozantinib, nivolumab and the combination of lenvatinib and everolimus have been approved in the second-line setting. As there is no direct co...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Kidney Cancer
Egile Nagusiak: Maia, Manuel Caitano, Dizman, Nazli, Salgia, Meghan, Pal, Sumanta Kumar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: IOS Press 2017
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6179120/
https://ncbi.nlm.nih.gov/pubmed/30334001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/KCA-170006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!